chrisvoncsefalvay/vaers-outcomes huggingface dataset:
When administering the Moderna Dose 2 in patient's left arm, the syringe  was defective and the vaccine solution dripped down the patient's arm to her elbow. It was significant enough that it did not appear as though she received the full or half the dose. I successfully re-vaccinated her in the right arm with a different syringe brand and another 0.5 ml dose.
7-2-08 swollen area at injection site, tender to touch, hurt to move his arm up and down, mom described the area to office staff on 7-3-08 as half size of tennis ball and the lump/swollen area was hard to touch. 7-3-08 seen in office Dx cellulitis upper arm: ordered KEFLEX for 10 days.
Irregular heartbeat; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 12Jan2022 02:45 (Lot number: 33036BD) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP7533, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 11Apr2021, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6204, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 21Mar2021, for COVID-19 immunization. The following information was reported: HEART RATE IRREGULAR (non-serious) with onset 13Jan2022 08:00, outcome "recovered", described as "Irregular heartbeat". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of heart rate irregular.  Additional information: The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination include hydrothiachlorizide. The patient didn't have covid prior vaccination, no known allergies and not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Seven hours after the shot, I felt very hungry. That evening, besides the pain in my arm from the shot, I had a headache and body aches. The next morning I had a fever of 100.3, nausea, body aches, and headache. By noon, my fever dropped to 99.6. By the second day after the shot, I began to feel better. Five days after the vaccine I have sinus congestion.
Information has been received from a physician concerning an adult patient who " over the last week", on approximately 07-OCT-2005, was vaccinated with 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide vaccine (lot 650453/0791P).  It was reported that the patient developed a severe local reaction at the injection site including, redness, swelling, and pain.  It was reported that the patient recovered or was recovering.  Unspecified medical attention was sought.  The reporter expressed concern about the lot 650453/0791P for pneumococcal 23v polysaccharide vaccine.  Additional information has been requested.  A lot checked has been requested.  The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory.  The lot complies with the standards and was released.
Fever of 102.8F (rectal) in less than 48 hours, post vax.
Heart palpitations. Frequency fluctuates and is much more noticeable after a heavy/fatty meal and more pronounced when lying down or in the reclining position.  I don't remember the exact time it started, but it was soon after my second dose. It became more pronounced after I had a meal with deep fried foods.
No adverse effects; administered VARIVAX and MMR II intramuscularly; This spontaneous report was received from a nurse regarding a 42 year old patient of unknown gender. The patient's pertinent medical history and drug reactions/allergies were not reported.  Concomitant medications included sterile diluent.  On 07-AUG-2019, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (lot # S001329, expiration date 14-JAN-2021) and varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # R035222, expiration date 04-DEC-2020) intramuscularly (dose, dose number and anatomical location were not reported for both vaccines). Both vaccines were administered for prophylaxis. No adverse effects were reported.
Pt recvd vax & approx 24 hrs later arm became swollen below the deltoid down to the elbow; approx 36 hrs later it was burning like fire & severely itching; also became red w/a knot below the inject site; seen by dialysis ctr med director;
25JUL91 2PM had shots; by 6PM started to get sick--hot, nausea, wouldn't eat; then PT began throwing fever 104, headache, listless & lifeless last 2 days; called ER about it;
Pt arm started to swell and get red later that night. The next day it began to itch. The red area spread from site toward the inner arm. No rash.
Patient denied receiving previous COVID vaccine at registration and vaccination station. Patient confirmed it was their first dose of Pfizer, Pfizer 0.3ml administered. While the patient was in observation, team member identified that the patient had two different profiles and patient had previously received the Johnson & Johnson vaccine at clinic on 4/10/21 at 8:30 am (lot # 202A21A) under a different profile. Patient was notified that cross vaccinating is not recommended by the CDC at this time and to follow up with their doctor. Patient waited in in observation for 30 minutes and denied experiencing any adverse reactions,
given 0.25 ml of the bivalent booster; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (given 0.25 ml of the bivalent booster) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (given 0.25 ml of the bivalent booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (given 0.25 ml of the bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (given 0.25 ml of the bivalent booster).    Concomitant medication was not provided.  Treatment information was not provided.
I had no adverse event from the vaccinations which were given in March, 2021. In JAN 2022 I developed a VERY mild case of Covid. I took two home tests that were positive and had a virtual call  with a physician.  I was fine after 10 days.
A nurse reported that a19 month old child received Acel-Immune and IPV vaccines on 5/24/2000. The next day, 5/26/00, the child developed an injection site reaction characterized by redness and swelling that extended from the Acel-Immune injection site at the left deltoid to the elbow. The child was also fussy at night. The child recovered. This is 1 out of 4 patients from this facility who had an adverse experience following receipt of Acel-Immune lot 469-396 or the concomitantly administered vaccines. A copy of the report has been forwarded to Aventis Pasteur, manufacturer of IPV.
The night following 2nd vaccine, I experienced fever, chills, headache , injection site muscle soreness and overall myalgia.
I initially spoke to the patient when she came to the vaccination clinic to receive her second dose of Moderna vaccine on 4/15/21.  At that time, I was called over to her table to discuss whether or not she should get the second dose.  The patient explained to me that she had not been doing well since she received her first dose of vaccine.  Her first dose was 3/18/21, administered on the right side.  After the first dose she had some rash, but also had more significant issues involving her joints on the side of her first injection.  I could see that she was having difficulty with her right wrist and hand.  She also said that she was having trouble with her knee.  I advised her at that time to take some time to see if those issue resolved and to speak to her provider before getting the second dose.  We agreed that she would let me know what the doctor told her. I received a follow-up phone call the week of 4/19/21.  She told me that her doctor advised her not to get the second dose because the rash was indicative of an allergic reaction.  Her doctor also told her that when she was vaccinated, the vaccinator likely hit a nerve and that is what is causing her joint issues. I heard from the patient again on 4/28/21.  She told me that she has started to see a neurologist for the issues that she is having.  She said that she was told that her problems were a result of the way the vaccine was administered and that the needle was ?way too high.?  She also mentioned that her daughter is a nurse and explained that there is a right place to inject in the arm.  She said that her wrist is horrible and that she can?t use her right hand.  Her knee and joints on the right side are bad, but the worst is her wrist and hand.
Patient developed dark red, streaky rash on crook of right arm within 15 minutes of receiving covid-19 vaccine. Rash was on the arm that received the injection.  Patient was monitored for an additional 20 minutes with no worsening of symptoms.  Followed up with patient the evening of  4/9/2021 and patients wife stated that patient had taken benadryl, still had rash, but overall was feeling fine.
p/vax pt devel diarrhea, vomiting & fever;pt hosp d/t dehydration;pt recovered & was disch on 6/23/99;
sporadic breakout of hives on face, torso and back for two days after vaccine, itchy throat, responded to Benedryl and Sarna lotion
Itchy, red splotch at injection site. That started a few days after the injection.
At 5 1/2 hours arm was hot, swollen, itchy and burning. Worsened overnight and lasted for 11 days. Looked like cellulitis, but did not travel. current at day 14 and injection site resolved, but is now peeling. Can still visually see where inflammation was. Also, had flu-like symptoms day after receiving vaccine (chills, fever, achy). Resolved after 36 hours.
Couldn't get up; Couldn't breathe; Lost voice; Felt very tired; A spontaneous report was received from a consumer concerning a 79 years old, female patient who received Moderna (mRNA-1273) vaccine and experienced couldn't get up/mobility decreased, couldn't breathe/dyspnoea , lost voice/aphonia and felt very tired/fatigue.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 13 Feb 2021, approximately three days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 022M20A) in the left arm for prophylaxis of COVID-19 infection.    15 Feb 2021, the patient couldn't breathe, felt very tired, lost her voice, couldn't get up, and was hospitalized following a visit to urgent care. Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, Dyspnoea, Fatigue, Aphonia, Movement disorder and Hospitalization was unknown.; Reporter's Comments: This case concerns a 79-year-old female who was hospitalized with serious unexpected events of dyspnea, mobility decreased, and aphonia and a serious expected event of fatigue.  The events occurred 3 days after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
4-5 inches of marked redness, swelling and warm to touch. Treatment:  Benadryl and Ibuprofen.
After the second shot I was sick with chills and arm hurts. The Firefighter gave me the vaccine and my arm was bleeding after the shot and turned red . My arm still is hurting where he gave me the shot.  The shoulder hurts and  it feels like pain . This firefighter stabs me in my arm with the needle and it still hurts
Injection administered without any problem. Seven days later, began feeling slow and achy. Fever as high as 102; pronounced and continuing lethargy and weakness. After six days of bed rest, fever hovers between 99 and 100. Body aches and powerful headaches have greatly abated. Note: This is extremely unusual for me.
Expiration date 25Mar2022, stored in the refrigerator 05Apr2022, Date administered 15Apr2022; expired vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine administered) and PRODUCT STORAGE ERROR (Expiration date 25Mar2022, stored in the refrigerator 05Apr2022, Date administered 15Apr2022) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033H21A, 076C21A, 027B21A and 032M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and URSODEOXYCHOLIC ACID (ACTIGALL) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 15-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 15-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expiration date 25Mar2022, stored in the refrigerator 05Apr2022, Date administered 15Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine administered) and PRODUCT STORAGE ERROR (Expiration date 25Mar2022, stored in the refrigerator 05Apr2022, Date administered 15Apr2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not reported The patients are not experiencing any symptoms after receiving the vaccine. Patient not ever had COVID + test or diagnosis. Patient not had allergies and Acute and Chronic illnesses at the time of vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2022: Follow-up received contains no new information
Diarrhea. So much watery, loose diarrhea; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Diarrhea. So much watery, loose diarrhea) in a 32year old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    No Medical History information was reported.   On 10-Dec-2021 at 11:15 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 02-Jun-2022 at 6:45 PM, the patient experienced DIARRHOEA (Diarrhea. So much watery, loose diarrhea). At the time of the report, DIARRHOEA (Diarrhea. So much watery, loose diarrhea) had not resolved. Not Provided          Concomitant product include -cold medicine from 31-MAY-2022.  Treatment details was not reported by the reporter.  Pfizer have permission to contact about this report but does not have permission to contact the patient's healthcare provider. The Device Date was reported as  02-Jun- 2022.
Induration of skin (12 cm x 12 cm); warmth of skin.  Patient received Ibuprofen/Ice education.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 76-year-old female patient who received SHINGRIX (batch number MX2LT, expiry date 29th May 2021) for prophylaxis. On 15th February 2019, the patient received the 1st dose of SHINGRIX. In February 2019, less than a week after receiving SHINGRIX, the patient experienced skin breakout. On 16th February 2019, the patient experienced shingles. On an unknown date, the outcome of the shingles and skin breakout were unknown. It was unknown if the reporter considered the shingles and skin breakout to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on left deltoid. The reporter stated that a patient received the SHINGRIX and broke out and went to the emergency room on 16th February 2019. The doctor there told her that the patient had Shingles. The reporter did not provide any additional details.
Ataxia, falling, repeated loss of tone of lower limbs, broad based gait, hyperlordotiz stance from 4 d after vax till ~5-6 d later (duration < 1wk).
All over body pain. Patient took acetaminophen 1g at 2:00AM on 12/4/2021. Had to take another dose at 9am and every 4 hours after for 24 hours to keep symptoms down. Symptoms resolved by 12/5/2021.
Itchy rash and bumps on upper body and in hairline.  Some disappeared with use of benadryl cream within a couple of hours.  Those in hairline and behind ears have itched for about 2 days.
Pt received HPV vaccine on 14 Apr 09. Pt went to urgent care clinic on 24 Apr 09 complaining that her right hand had been numb for the past 6 days. Pt received Gardasil in left arm. When pt came in for 2nd series pt states her hand is still numb and believes it may be related to the Gardasil vaccine.
Patient had syncope in waiting room after checking out at front desk. States felt fine initially after receiving vaccine but then started feeling dizzy and faint after walking around.  Patient was sitting in chair and was diaphoretic and pale when I entered the waiting room after being called to the front for assistance. She was talking to our APRN and stated this has happened to her before. Stated she had not eaten today. Assisted by wheelchair to bed, placed in supine position. BP 103/71 P 79 O2 Sat 97%.  Five minutes sitting BP 105/74. After another five minutes Standing BP 108/79 P 81.  Given orange juice and pretzels to take with her since had not eaten. Stated feeling much better and left with fiancé.
swollen lymph node under left arm; tiredness; dizzy; soreness in shoulders up neck and back of left side of head; soreness in shoulders up neck and back of left side of head; This is a spontaneous report from a non-contactable consumer, the patient. A 50-years-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 29Mar2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included Covid-19. The patient previously received cyclobenzaprine hydrochloride (FLEXERIL) on an unspecified date for an unknown indication and experienced drug allergy. Concomitant medications included allergy medicine from an unknown date for an unknown indication. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Mar2021 at 11:00, the patient experienced swollen lymph node under left arm, tiredness, dizzy, soreness in shoulders up neck and back of left side of head. No therapeutic measures were taken as the result of the reported adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen lymph node under left arm, tiredness, dizzy, soreness in shoulders up neck and back of left side of head were resolving at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Individual was vaccinated with J&J vaccine while age < 18 years.  No adverse reaction to the vaccine known at time of VAERS form completion.
Client c/o continued headaches 2-3 days pain level was about (5).  States temp 102.6 for 2 days.  Also having chills up to present.
Excessive local reaction with redness, swelling and tenderness, peak extension of erythema and edema to 13x13.5 cm at 48 hours after vaccine.  No systemic symptoms.
PATIENT EXPERIENCED REDNESS, TENDERNESS, IRRITATION, SWELLING, AND FEVER AT THE INJECTION SITE APROXIMATELY 3 HOURS AFTER INJECTION. NO INITIAL SYMPTOMS WERE NOTICED IMMEDIATELY AFTER INJECTION. AFTER THE FIRST DAY SYMPTOMS SPREAD THROUGHOUT ARM OF INJECTION SITE. SHE WENT.
felt like she had a cold; itchy ankles; joint pain around her ankle; small red bumps; injection site started to itch; red raised bump "quarter size"; injection site feels warm; swollen in the arm pit; large lymph nodes; sore arm; mild fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MALAISE (felt like she had a cold), PRURITUS (itchy ankles), VACCINATION SITE MASS (red raised bump "quarter size") and ARTHRALGIA (joint pain around her ankle) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IBUPROFEN (IBU) for an unknown indication.    No medical history was provided by the reporter.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started IBUPROFEN (IBU) (unknown route) at an unspecified dose. On 11-Jan-2021, the patient experienced FATIGUE (mild fatigue). On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 16-Jan-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (large lymph nodes). On 18-Jan-2021, the patient experienced VACCINATION SITE MASS (red raised bump "quarter size"), VACCINATION SITE WARMTH (injection site feels warm) and VACCINATION SITE PRURITUS (injection site started to itch). On 19-Jan-2021, the patient experienced MALAISE (felt like she had a cold), PRURITUS (itchy ankles), ARTHRALGIA (joint pain around her ankle) and VACCINATION SITE RASH (small red bumps). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), MALAISE (felt like she had a cold), PRURITUS (itchy ankles), VACCINATION SITE MASS (red raised bump "quarter size"), ARTHRALGIA (joint pain around her ankle), VACCINATION SITE LYMPHADENOPATHY (large lymph nodes), VACCINATION SITE WARMTH (injection site feels warm), VACCINATION SITE RASH (small red bumps), VACCINATION SITE PRURITUS (injection site started to itch) and FATIGUE (mild fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
On  February 1st, I woke up at 4am with fever and chills and went and got tested for covid on February the 3rdand tested positive. I then experienced the same symptoms for the next 3 to 4 days and it worsened by Thursday and lasted u to 2weeks. I just took Tylenol for the next few days after the 3rd and that's what kept my body ache and fever down.